Loading...
Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria
Hutchinson-Gilford progeria syndrome (HGPS) is caused by the accumulation of a farnesylated form of prelamin A (progerin). Previously, we showed that blocking protein farnesylation with a farnesyltransferase inhibitor (FTI) ameliorates the disease phenotypes in mouse model of HGPS (Lmna(HG/+)). Howe...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
The American Society for Biochemistry and Molecular Biology
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2803242/ https://ncbi.nlm.nih.gov/pubmed/19965595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M002808 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|